Lichen striatus associated with etanercept treatment of rheumatoid arthritis

J Am Acad Dermatol. 2014 Apr;70(4):e90-e92. doi: 10.1016/j.jaad.2013.11.039.

Authors

Viviana Lora¹, Jean Kanitakis², Alessandra Latini¹, Carlo Cota³

Affiliations

¹ Division of Dermatology, San Gallicano Dermatological Institute, Rome, Italy.
² Department of Dermatology, Ed Herriot Hospital Group, Lyon, France.
³ Dermatopathology Unit, San Gallicano Dermatological Institute, Rome, Italy. Electronic address: carlocota@yahoo.it.

PMID: 24629374
DOI: 10.1016/j.jaad.2013.11.039

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Aged
Antirheumatic Agents / adverse effects*
Antirheumatic Agents / therapeutic use
Arthritis, Rheumatoid / diagnosis
Arthritis, Rheumatoid / drug therapy*
Biopsy, Needle
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Eruptions / etiology*
Drug Eruptions / pathology*
Etanercept
Female
Follow-Up Studies
Humans
Immunoglobulin G / adverse effects*
Immunoglobulin G / therapeutic use
Immunohistochemistry
Lichen Planus / chemically induced*
Lichen Planus / drug therapy
Lichen Planus / pathology*
Rare Diseases
Receptors, Tumor Necrosis Factor / therapeutic use
Risk Assessment
Severity of Illness Index
Treatment Outcome

Substances

Adrenal Cortex Hormones
Antirheumatic Agents
Immunoglobulin G
Receptors, Tumor Necrosis Factor
Etanercept